Bunkyo, Japan

Katsuharu Tsuchida

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Juntendo Educational Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuharu Tsuchida. Retrieved from https://idiyas.com/inventor/katsuharu-tsuchida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsuharu Tsuchida

Introduction

Katsuharu Tsuchida is a notable inventor based in Bunkyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hypertrophic cardiomyopathy. His work has led to the development of innovative therapeutic agents that aim to improve patient outcomes.

Latest Patents

Katsuharu Tsuchida holds a patent for a therapeutic agent specifically designed for hypertrophic cardiomyopathy. This patent represents a crucial advancement in the medical field, addressing a condition that affects many individuals worldwide. The patent is a testament to his dedication to improving healthcare through innovation. He has 1 patent to his name.

Career Highlights

Tsukida is affiliated with the Juntendo Educational Foundation, where he continues to engage in research and development. His work at this esteemed institution has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science.

Collaborations

Throughout his career, Katsuharu Tsuchida has worked alongside notable colleagues such as Hideo Saotome and Osamu Minowa. These collaborations have fostered a rich environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Katsuharu Tsuchida's work exemplifies the impact of innovation in medicine. His dedication to developing therapeutic agents for hypertrophic cardiomyopathy highlights the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…